glp 1 clinical trials GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes Revising our earlier interpretation of

(2012) Management of hyperglycaemia in type 2 diabetes: a patient-centered approach

While Mounjaro is known for effectively reducing A1C levels and weight, Ozempic also addresses cardiovascular risks associated with Type 2 diabetes

Sun Pharma's Noveltreat and Alkem's brands both conducted India-specific Phase III trials

And its significant to note that some patients have reported reduced cravings while using dulaglutide for weight loss

Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial

Footnotes The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: GAS declares potential conflict of interest as a research consultant to Wellcoaches